IPP Bureau

Astec LifeSciences Q1 FY26 revenue up 30.3%
Astec LifeSciences Q1 FY26 revenue up 30.3%

By IPP Bureau - July 29, 2025

The company reported consolidated EBITDA loss of Rs. 10.5 crore in Q1 FY26 as compared to loss of Rs. 45.3 crore in the same period last year

Healthians elevates Nishant Singhal as CEO
Healthians elevates Nishant Singhal as CEO

By IPP Bureau - July 28, 2025

Singhal brings a powerful blend of operational excellence, investor acumen, and visionary thinking

Syngene International appoints Gaurav Kushwaha as CTO
Syngene International appoints Gaurav Kushwaha as CTO

By IPP Bureau - July 28, 2025

Kushwaha previously served as Chief Digital & Information Officer at Jubilant Ingrevia Limited

Jubilant Biosys appoints Venugopala Reddy Pagadala as VP&CFO - CRDMO
Jubilant Biosys appoints Venugopala Reddy Pagadala as VP&CFO - CRDMO

By IPP Bureau - July 28, 2025

His career spans notable tenures at Syngene International Limited, Cipla, Nestlé, and Bharat Petroleum Corporation Limited

Laurus Labs allotted 531.77 acres of land by the Govt. of Andhra Pradesh
Laurus Labs allotted 531.77 acres of land by the Govt. of Andhra Pradesh

By IPP Bureau - July 28, 2025

The company has projected Rs. 5,630 crores of investment and to provide employment to 6,350 people in three phases over a period of eight years

10.18 Cr women screened for cervical cancer under Govt. schemes
10.18 Cr women screened for cervical cancer under Govt. schemes

By IPP Bureau - July 28, 2025

This achievement is part of the population-based initiative for screening, prevention, and management of Non-Communicable Diseases

UK journal publishes complex case of severe pan-drug resistant infection in US liver transplant patient successfully treated with Zaynich
UK journal publishes complex case of severe pan-drug resistant infection in US liver transplant patient successfully treated with Zaynich

By IPP Bureau - July 28, 2025

This case report is jointly authored by US clinicians from leading hospitals, Houston Methodist Hospital, Weill Cornell Medical College and Johns Hopkins

Akums’ Haridwar factory receives ANVISA GMP certification for sterile manufacturing plant
Akums’ Haridwar factory receives ANVISA GMP certification for sterile manufacturing plant

By IPP Bureau - July 28, 2025

This certification validates the plant’s robust capabilities in manufacturing a wide range of sterile dosage forms

GSK forges $12 billion alliance with Hengrui Pharma
GSK forges $12 billion alliance with Hengrui Pharma

By IPP Bureau - July 28, 2025

GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

Dr. Reddy’s re-appoints G V Prasad as Co-Chairman and Managing Director
Dr. Reddy’s re-appoints G V Prasad as Co-Chairman and Managing Director

By IPP Bureau - July 27, 2025

Prasad has played a key role in shaping Dr. Reddy’s into a globally respected organisation

Granules India CEO K V Sitaram Rao resigns
Granules India CEO K V Sitaram Rao resigns

By IPP Bureau - July 27, 2025

Dr. Rao has over 29 years of experience in manufacturing, R&D, business operations, and customer service

Sigachi Industries reports Q1 FY26 consolidated loss at Rs. 100.35 Cr
Sigachi Industries reports Q1 FY26 consolidated loss at Rs. 100.35 Cr

By IPP Bureau - July 27, 2025

Sigachi Industries has reported total income of Rs. 132.18 crores during the period ended June 30, 2025

Sigachi Industries begins disbursing Interim ex-gratia to families of deceased
Sigachi Industries begins disbursing Interim ex-gratia to families of deceased

By IPP Bureau - July 27, 2025

EMA’s CHMP recommends authorization of Moderna's Covid-19 vaccine Spikevax for SARS-CoV-2 Variant LP.8.1
EMA’s CHMP recommends authorization of Moderna's Covid-19 vaccine Spikevax for SARS-CoV-2 Variant LP.8.1

By IPP Bureau - July 27, 2025

Moderna's updated COVID-19 mRNA vaccine will be available for the 2025-2026 vaccination season, pending a European Commission authorization decision

Laurus Labs to invest €5 million in JV KRKA Pharma
Laurus Labs to invest €5 million in JV KRKA Pharma

By IPP Bureau - July 27, 2025

The purpose of this investment is to meet the expenditure relating to the civil works to be undertaken for setting up of a manufacturing facility

Latest Stories

Interviews

Packaging